Interestingly, when comparing baseline H3KAc levels between cancer types and stratifying by IDH status, only glioma showed a significant difference in H3KAc, thus suggesting a unique effect of IDHmut in gliomas versus other cancers with different epigenomic landscapes (Figure 1F). This evidence concerns the gene IDH1 and central nervous system cancer.